Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Cephalon data

Cephalon Inc.
Cephalon Inc. said that in a Phase I trial of its Myotrophin insulin-like growth factor-1 in 10 patients with

Read the full 222 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE